6533b870fe1ef96bd12cf6e4
RESEARCH PRODUCT
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
Gridelli CGallo CCeribelli AVittorio GebbiaGamucci TCiardiello FCarozza FFavaretto ADaniele BGaletta DBarbera SRosetti FRossi AMaione PCognetti FTesta ADi Maio MMorabito APerrone FGeco Investigatorssubject
trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung canceryear | journal | country | edition | language |
---|---|---|---|---|
2007-01-01 |